It has been elucidated that cholinergic deficiency is associated with AD [4]; therefore, one of the major therapeutic strategies is to inhibit the biological activity of AChE, and hence, to increase the acetylcholine level in the brain. This evidence concerns the gene ACHE and Alzheimer disease.